{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.196.12.1501",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2021-02-11T10:17:19.000-05:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "NCQA PHEMUR Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2022-12-15"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2021-02-11"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1501",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1501"
  }],
  "version" : "20180310",
  "name" : "Hyoscyamine",
  "title" : "Hyoscyamine",
  "status" : "active",
  "experimental" : false,
  "date" : "2018-03-10T01:00:08-05:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for hyoscyamine.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable hyoscyamine.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs and excludes concepts that represent components or ingredients and hyoscyamine in combination with other medications.)",
  "compose" : {
    "include" : [{
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1508"]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:13660dd0-61db-4753-bbb8-3360a63b8e68",
    "timestamp" : "2023-09-26T10:59:01-04:00",
    "total" : 20,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1037234",
      "display" : "benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1046770",
      "display" : "12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1046787",
      "display" : "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1046815",
      "display" : "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1046982",
      "display" : "hyoscyamine sulfate 0.125 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1046985",
      "display" : "hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1046997",
      "display" : "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1047786",
      "display" : "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1047881",
      "display" : "hyoscyamine sulfate 0.025 MG/ML Oral Solution"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1047895",
      "display" : "hyoscyamine sulfate 0.125 MG/ML Oral Solution"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1047905",
      "display" : "hyoscyamine sulfate 0.125 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1047916",
      "display" : "1 ML hyoscyamine sulfate 0.5 MG/ML Injection"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1048124",
      "display" : "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1048307",
      "display" : "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1048336",
      "display" : "hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1050325",
      "display" : "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1087365",
      "display" : "hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1440869",
      "display" : "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1807886",
      "display" : "Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "998726",
      "display" : "hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule"
    }]
  }
}